DIHEXA Caps (10mg)
For Research Use Only — Not for Human Use
Intended for laboratory research use only (e.g., analytical and in-vitro studies). Not for human use.
DIHEXA (N-Hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptide-derived compound studied in neuroscience and synaptic signaling research. This capsule format delivers DIHEXA in a stabilized encapsulated format for laboratory research use.
Researchers study DIHEXA primarily for its interaction with hepatocyte growth factor (HGF) and c-Met receptor signaling pathways, which are associated with synaptic connectivity and neural communication.
GENIQ supplies DIHEXA Caps strictly for laboratory research only—not for human or animal use.
$199.99
-
Official retailer -
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is DIHEXA Caps?
DIHEXA (N-Hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptide-derived compound studied in neuroscience and synaptic signaling research. This capsule format delivers DIHEXA in a stabilized encapsulated format for laboratory research use.Researchers study DIHEXA primarily for its interaction with hepatocyte growth factor (HGF) and c-Met receptor signaling pathways, which are associated with synaptic connectivity and neural communication.GENIQ supplies DIHEXA Caps strictly for laboratory research only—not for human or animal use.
Peptide Overview
DIHEXA is frequently studied in research focused on neurobiology, synaptic plasticity, and cellular signaling within the central nervous system. In controlled laboratory environments, researchers examine how DIHEXA Caps may promote changes in:
| Synaptogenesis-related signaling pathways |
| Neuronal growth and connectivity markers |
| Hepatocyte growth factor (HGF) receptor activity |
| Neuroplasticity-associated gene expression |
| Memory and learning molecular pathways |
| Neural cell communication models |
| Brain-derived signaling and structural protein activity |
All findings remain limited to preclinical and in-vitro experimental environments.
History of DIHEXA Caps
DIHEXA was developed during research aimed at modifying angiotensin IV analogs to create molecules capable of interacting with neural growth signaling pathways. Scientists discovered that DIHEXA binds to hepatocyte growth factor (HGF), a protein involved in neuronal development and synaptic connectivity. Because of this interaction, DIHEXA became a compound of interest in studies involving:
| Synaptic formation and plasticity |
| Neurodegenerative disease models |
| Learning and memory mechanisms |
| Neural growth signaling pathways |
| HGF/c-Met receptor system interactions |
| Brain cellular communication models |
Peptide Structure
Chemical Name: N-Hexanoic-Tyr-Ile-(6) aminohexanoic amide Derived From: Angiotensin IV analog Form Supplied: Oral capsule, 10mg per capsule (60 capsules per bottle)
Certificates of Analysis
Every batch of GENIQ DIHEXA Caps is verified by third-party laboratory testing confirming identity, purity, and capsule content accuracy. Certificates of Analysis (COA) are available upon request for research verification.
Research Findings
Research involving DIHEXA commonly focuses on:
| Synaptic formation signaling: Studies evaluate molecular pathways associated with new synapse development. |
| HGF/c-Met receptor activity: Researchers investigate how DIHEXA interacts with hepatocyte growth factor signaling systems. |
| Neuroplasticity markers: Laboratory models track biochemical changes related to neuronal connectivity and structural proteins. |
| Memory and learning pathways: Experimental studies analyze cellular processes associated with cognitive signaling networks. |
| Gene-expression modulation: Investigations explore transcriptional activity related to neurodevelopmental pathways. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
FAQ
Are GENIQ peptides pharmaceutical products?
No. They are not drugs, supplements, or therapeutic items. All compounds are provided strictly for laboratory research.
Who should purchase GENIQ research materials?
Qualified researchers, laboratories, and institutions working within applicable laws and regulations.
Do orders include COAs?
Yes. Each peptide includes a Certificate of Analysis confirming identity and purity testing when available for that lot.
What handling notes does GENIQ provide?
Only storage temperature and solvent-compatibility notes when listed on the product page. GENIQ does not provide guidance on preparation or application. Buyers follow their institution’s laboratory protocols.
Are these products for human use?
No. For Research Use Only — Not for Human Use. Not for human or animal consumption.
For Research Use Only — Not for Human Use
Sold exclusively as laboratory research materials. Not for human or animal consumption, clinical use, or household use.
Intended research use: Laboratory and in-vitro research, including analytical characterization and pathway / receptor-binding studies as applicable to this compound. Not for human consumption, clinical use, or diagnostic use on humans.
DIHEXA (N-Hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptide-derived compound studied in neuroscience and synaptic signaling research. This capsule format delivers DIHEXA in a stabilized encapsulated format for laboratory research use.
Researchers study DIHEXA primarily for its interaction with hepatocyte growth factor (HGF) and c-Met receptor signaling pathways, which are associated with synaptic connectivity and neural communication.
GENIQ supplies DIHEXA Caps strictly for laboratory research only—not for human or animal use.
